These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 28643049)

  • 21. Psychopharmacology of Persistent Violence and Aggression.
    Meyer JM; Cummings MA; Proctor G; Stahl SM
    Psychiatr Clin North Am; 2016 Dec; 39(4):541-556. PubMed ID: 27836150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.
    Moore TA; Buchanan RW; Buckley PF; Chiles JA; Conley RR; Crismon ML; Essock SM; Finnerty M; Marder SR; Miller DD; McEvoy JP; Robinson DG; Schooler NR; Shon SP; Stroup TS; Miller AL
    J Clin Psychiatry; 2007 Nov; 68(11):1751-62. PubMed ID: 18052569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 24. The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
    Spivak B; Shabash E; Sheitman B; Weizman A; Mester R
    J Clin Psychiatry; 2003 Jul; 64(7):755-60. PubMed ID: 12934974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reducing Restraint With Clozapine in Involuntarily Admitted Patients With Schizophrenia.
    Ifteni P; Szalontay AS; Teodorescu A
    Am J Ther; 2017; 24(2):e222-e226. PubMed ID: 27984264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Violence in schizophrenia and bipolar disorder.
    Volavka J
    Psychiatr Danub; 2013 Mar; 25(1):24-33. PubMed ID: 23470603
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of violence in schizophrenia and implications for long-term treatment.
    Volavka J; Citrome L
    Int J Clin Pract; 2008 Aug; 62(8):1237-45. PubMed ID: 18564202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduction of aggressiveness and impulsiveness during clozapine treatment in chronic neuroleptic-resistant schizophrenic patients.
    Spivak B; Mester R; Wittenberg N; Maman Z; Weizman A
    Clin Neuropharmacol; 1997 Oct; 20(5):442-6. PubMed ID: 9331521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The pharmacological management of violence in schizophrenia: a structured review.
    Topiwala A; Fazel S
    Expert Rev Neurother; 2011 Jan; 11(1):53-63. PubMed ID: 21158555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulants for impulsive violence in schizophrenia spectrum disordered women: a case series and brief review.
    Skoretz P; Tang C
    CNS Spectr; 2016 Dec; 21(6):445-449. PubMed ID: 27181114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Violence and phases of illness: differential risk and predictors.
    Hodgins S; Riaz M
    Eur Psychiatry; 2011 Nov; 26(8):518-24. PubMed ID: 21277752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Executive function predicts response to antiaggression treatment in schizophrenia: a randomized controlled trial.
    Krakowski MI; Czobor P
    J Clin Psychiatry; 2012 Jan; 73(1):74-80. PubMed ID: 22152404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine: its impact on aggressive behavior among children and adolescents with schizophrenia.
    Kranzler H; Roofeh D; Gerbino-Rosen G; Dombrowski C; McMeniman M; DeThomas C; Frederickson A; Nusser L; Bienstock MD; Fisch GS; Kumra S
    J Am Acad Child Adolesc Psychiatry; 2005 Jan; 44(1):55-63. PubMed ID: 15608544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 5α-reductase inhibitor finasteride increases suicide-related aggressive behaviors and blocks clozapine-induced beneficial effects in an animal model of schizophrenia.
    Maurice-Gélinas C; Deslauriers J; Monpays C; Sarret P; Grignon S
    Physiol Behav; 2018 Jul; 191():65-72. PubMed ID: 29630964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of clozapine on physical and verbal aggression.
    Rabinowitz J; Avnon M; Rosenberg V
    Schizophr Res; 1996 Dec; 22(3):249-55. PubMed ID: 9000322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-acting injectable antipsychotics for prevention and management of violent behaviour in psychotic patients.
    Mohr P; Knytl P; Voráčková V; Bravermanová A; Melicher T
    Int J Clin Pract; 2017 Sep; 71(9):. PubMed ID: 28869705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Legal Right to Clozapine Therapy for Incarcerated Individuals With Treatment-Resistant Schizophrenia.
    Zarzar TR; Williams JB; Pruette ME; Sheitman BB
    Psychiatr Serv; 2021 Apr; 72(4):482-484. PubMed ID: 33593106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refractory schizophrenia: what works pharmacologically?
    Sousa S
    J Psychosoc Nurs Ment Health Serv; 1999 Feb; 37(2):19-23. PubMed ID: 10023603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurolipidomics in schizophrenia: A not so well-oiled machine.
    Del Campo CMZ; Nicolson GL; Sfera A
    Neuropharmacology; 2024 Dec; 260():110117. PubMed ID: 39153730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility.
    Beck NC; Greenfield SR; Gotham H; Menditto AA; Stuve P; Hemme CA
    J Am Acad Psychiatry Law; 1997; 25(4):461-8. PubMed ID: 9460034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.